The Week in Review: February 16 – February 23, 2018

Friday, February 23, 2018 News Recap: Way to Go, Ontario! Ontario removes fibrosis requirement for HCV treatment effective Feb 28th.  Action Hepatitis Canada has just shared some great news: Ontario has announced today that effective February 28, 2018, the fibrosis requirement for hepatitis C treatment will be removed! Finally, diagnosis of chronic hepatitis C and genotyping is all that will be required in Ontario to access treatment. This announcem...

Significant Mortality Benefit Seen With Sustained HCV Virologic Response With DAAs

For patients infected with hepatitis C virus(HCV) without advanced liver disease, achieving sustained virologic response with direct-acting antivirals (DAAs) is associated with decreased mortality, according to results published in Hepatology. The mortality rate of patients who achieved sustained virologic response was 1.18 deaths/100 patient years compared with 2.84 deaths/100 patient years for patients who did not achieve sustained virologic response, a